GlaxoSmithKline has announced it plans to downsize its Sterile Injectables division, a move that will drastically reduce the workforce in Ulverston site (UK), that focuses on sterile liquids.
Ulverston employs 347 people, 191 of which will lose their jobs starting from June 2019. The drastic decision is part of the GBP400m price cut plan, announced by CEO Emma Walmsley soon after she was appointed. GSK has announced 165 dismissals in Sligo, Ireland, over the last months, and 1,000 in Bangladesh.
(Source: In Cumbria)